GlaxoSmithKline Balance Sheet
View: Annual
This data is provided as per license from EDGAR Online
| Assets | Dec 07 | Dec 06 | Dec 05 |
|---|---|---|---|
| Current Assets | |||
| Cash | 10,000.5 | -- | 9,006.7 |
| Net Receivables | 11,091.0 | -- | 9,918.7 |
| Inventories | 6,123.7 | -- | 3,749.6 |
| Other Current Assets | -- | -- | -- |
| Total Current Assets | 27,215.2 | -- | 22,675.0 |
| Net Fixed Assets | 15,620.9 | -- | 11,503.5 |
| Other Noncurrent Assets | 19,086.2 | -- | 65,514.3 |
| Total Assets | 61,922.3 | -- | 99,692.8 |
| Liabilities and Shareholder's Equity | Dec 07 | Dec 06 | Dec 05 |
| Current Liabilities | |||
| Accounts Payable | 11,262.8 | -- | 12,761.5 |
| Short-Term Debt | 7,521.8 | -- | 2,065.0 |
| Other Current Liabilities | 1,877.5 | -- | 1,540.1 |
| Total Current Liabilities | 20,662.1 | -- | 16,366.5 |
| Long-Term Debt | 14,130.9 | -- | 9,127.1 |
| Other Noncurrent Liabilities | 7,949.3 | -- | 15,206.7 |
| Total Liabilities | 42,742.2 | -- | 40,700.4 |
|
Shareholder's Equity | |||
| Preferred Stock Equity | -- | -- | -- |
| Common Stock Equity | 19,180.1 | -- | 58,992.5 |
| Total Equity | 19,180.1 | -- | 58,992.5 |
| Shares Outstanding (mil.) | 427.0 | 0.0 | 401.1 |
This data is provided as per license from EDGAR Online
